“医药一哥”被放鸽子,又一个国产创新药BD交易遭“退货”

北京药研汇
Mar 11

近年来,中国创新药BD交易市场火热。数据显示,2025年中国创新药出海实现爆发式增长,全年创新药对外授权(BD)交易总金额超过1300亿美元,授权交易数量超过150笔。另有报告显示,2026年1—2月中国创新药BD交易总额达532.76亿美元,交易数量达44笔。但是创新药出海火热的同时,被退货事件也时有发生。近日,知名跨国药企默克宣布终止与“医药一哥”恒瑞医药围绕PARP1抑制剂HRS-1167的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10